Literature DB >> 20033770

The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.

Chan H Han1, Jiachun Lu, Qingyi Wei, Melissa L Bondy, Abenaa M Brewster, Tse-Kuan Yu, Thomas A Buchholz, Banu K Arun, Li-E Wang.   

Abstract

PIN1, an isomerase that causes conformational changes in proteins, plays an important role in mammary epithelial cell growth both physiologically and pathologically. Thus, genetic variants in the PIN1 gene may alter protein function and cancer risk. We have previously demonstrated an association between a PIN1 promoter variant (-842G>C; rs2233678) and risk of squamous cell carcinoma of the head and neck, a finding supported by additional functional data. In the present study, we genotyped two promoter single nucleotide polymorphisms (SNPs) (-842G>C, rs2233678 and -667T>C, rs2233679) and one synonymous SNP (Gln33Gln; G>A, rs2233682) in exon 2 to evaluate their associations with risk of sporadic breast cancer in non-Hispanic white women 55 years and younger. We found that the carriers of -842C variant alleles had decreased risk of breast cancer with an adjusted odd ratio (OR) of 0.67 and 95% confidence interval (CI) of 0.50-0.90. This reduced risk was more evident in women after reproductive age of 45 (OR = 0.63, 95% CI = 0.42-0.93), ever-smokers (OR = 0.56, 95% CI = 0.36-0.88), and ever-drinkers (OR = 0.67, 95% CI = 0.45-0.99). No such associations were observed for PIN1 -667T>C and PIN1 Gln33Gln. However, the haplotypes of these three SNPs were also associated with reduced risk of breast cancer. In conclusion, the PIN1 polymorphisms may contribute to the etiology of sporadic breast cancer in non-Hispanic white women 55 years and younger. Further validation in large population-based studies is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033770      PMCID: PMC2883663          DOI: 10.1007/s10549-009-0682-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  40 in total

1.  Signal transduction. Grabbing phosphoproteins.

Authors:  M B Yaffe; L C Cantley
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

2.  Pin1 acts catalytically to promote a conformational change in Cdc25.

Authors:  P T Stukenberg; M W Kirschner
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

Review 3.  ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics.

Authors:  K McPherson; C M Steel; J M Dixon
Journal:  BMJ       Date:  2000-09-09

4.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.

Authors:  X Z Zhou; O Kops; A Werner; P J Lu; M Shen; G Stoller; G Küllertz; M Stark; G Fischer; K P Lu
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

5.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

6.  Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.

Authors:  Yih-Cherng Liou; Akihide Ryo; Han-Kuei Huang; Pei-Jung Lu; Roderick Bronson; Fumihiro Fujimori; Takafumi Uchida; Tony Hunter; Kun Ping Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 7.  Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.

Authors:  X Z Zhou; P J Lu; G Wulf; K P Lu
Journal:  Cell Mol Life Sci       Date:  1999-11-30       Impact factor: 9.261

8.  Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.

Authors:  A Ryo; M Nakamura; G Wulf; Y C Liou; K P Lu
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

Review 9.  Pinning down proline-directed phosphorylation signaling.

Authors:  Kun Ping Lu; Yih Cherng Liou; Xiao Zhen Zhou
Journal:  Trends Cell Biol       Date:  2002-04       Impact factor: 20.808

10.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

View more
  20 in total

1.  A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.

Authors:  Suk Ling Ma; Nelson Leung Sang Tang; Cindy Woon Chi Tam; Victor Wing Cheong Lui; Linda Chiu Wa Lam; Helen Fung Kum Chiu; Jane Ann Driver; Lucia Pastorino; Kun Ping Lu
Journal:  Neurobiol Aging       Date:  2010-06-30       Impact factor: 4.673

2.  Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.

Authors:  Man-Li Luo; Chang Gong; Chun-Hau Chen; Daniel Y Lee; Hai Hu; Pengyu Huang; Yandan Yao; Wenjun Guo; Ferenc Reinhardt; Gerburg Wulf; Judy Lieberman; Xiao Zhen Zhou; Erwei Song; Kun Ping Lu
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

3.  Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population.

Authors:  Yonghe You; Jieqiong Deng; Jian Zheng; Lan Jiang; Na Li; Hongchun Wu; Wei Li; Jiachun Lu; Yifeng Zhou; Bin Ni
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

4.  A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.

Authors:  Dayun Yang; Wensong Luo; Jichuang Wang; Min Zheng; Xin-Hua Liao; Nan Zhang; Wenxian Lu; Long Wang; Ai-Zheng Chen; Wen-Guo Wu; Hekun Liu; Shi-Bin Wang; Xiao Zhen Zhou; Kun Ping Lu
Journal:  J Control Release       Date:  2017-11-21       Impact factor: 9.776

Review 5.  PIN1 in breast development and cancer: a clinical perspective.

Authors:  Alessandra Rustighi; Alessandro Zannini; Elena Campaner; Yari Ciani; Silvano Piazza; Giannino Del Sal
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

6.  Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.

Authors:  Li Zhenzhen; Sun Ning; Liu Xianghua
Journal:  Tumour Biol       Date:  2013-08-28

7.  PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.

Authors:  Li Huang; Zhuning Mo; Xianjun Lao; Xiaolian Zhang; Yanqiong Liu; Jingzhe Sui; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2015-12-07

8.  Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma.

Authors:  Yan Lu; Guo-Liang Huang; Xing-Xiang Pu; Yu-Xiang He; Bin-Bin Li; Xing-Yan Liu; Zigang Dong; Zhiwei He
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

9.  Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.

Authors:  Xiaoxiang Guan; Hongliang Liu; Jingfang Ju; Yangkai Li; Peng Li; Li-E Wang; Abenaa M Brewster; Thomas A Buchholz; Banu K Arun; Qingyi Wei; Zhensheng Liu
Journal:  Mol Carcinog       Date:  2013-10-26       Impact factor: 4.784

10.  SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function.

Authors:  Chun-Hau Chen; Che-Chang Chang; Tae Ho Lee; Manli Luo; Pengyu Huang; Pei-Hsin Liao; Shuo Wei; Fu-An Li; Ruey-Hwa Chen; Xiao Zhen Zhou; Hsiu-Ming Shih; Kun Ping Lu
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.